LUKE PEARSALL: Open Payments
NPI 1134177306 · WINSTON-SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$240 in 13 payments from 8 companies in 2025. Trend: 2023 $334 · 2024 $247 · 2025 $240
Food & beverage: $240
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $54 |
| Regeneron Healthcare Solutions, Inc. | 3 | $53 |
| GlaxoSmithKline, LLC. | 3 | $47 |
| PFIZER INC. | 1 | $20 |
| Viatris Specialty LLC | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| Verona Pharma, Inc. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: OFEV, DUPIXENT, NUCALA, ELIQUIS, YUPELRI, ZERBAXA, Ohtuvayre, FASENRA.
Industry payments across NC — which companies pay providers there.
